Author

Natacha Faivre

Centre National de la Recherche ScientifiqueORCID 0009-0008-0330-5519Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

Christel VérolletiD· 3 shared Geanncarlo Lugo‐VillarinoiD· 3 shared Olivier NeyrollesiD· 3 shared Arnaud MétaisiD· 2 shared Brigitte Raynaud‐MessinaiD· 2 shared Joaquina Barros· 2 shared Luciana BalboaiD· 2 shared Mariano Maio· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Christel VérolletORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyMicrobiology SpectrumPeer-reviewedMay 11, 2026

Dual human lung models reveal compartment-specific activity of anti-tuberculosis drugs and host-directed therapies

Caio César Barbosa Bomfim, Natacha Faivre, Thomas Benoist…·Céline Cougoule

This study uses dual human lung models to evaluate anti-tuberculosis drugs and host-directed therapies, revealing compartment-specific efficacy and immune responses.

DOI 10.1128/spectrum.03729-25

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyLife Science AlliancePeer-reviewedFeb 7, 2026

Inhibition of glycolysis in tuberculosis-mediated metabolic rewiring reduces HIV-1 spread across macrophages

Zoï Vahlas, Clara Deyts, Steven G. Fried…·Christel Vérollet

This study shows that inhibiting glycolysis in TB-infected macrophages reduces HIV-1 spread by blocking tunneling nanotubes and Siglec-1 expression.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintJul 7, 2025

Lipid-mediated GPR32 signaling reprograms macrophage metabolism to impair anti-tuberculous immunity

Joaquina Barros, Leandro Ferrini, Mariano Maio…·Luciana Balboa

The paper identifies RvD5-GPR32 signaling as a mechanism by which TB-PE reprograms macrophage metabolism to impair anti-tuberculous immunity.

DOI 10.1101/2025.07.07.663524

humanbulk RNA-seq

𝕏 PostBluesky